secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGILE THERAPEUTICS INC (—)
CIK:        0001261249
Form:       8-K
Filed at:   2023-03-30T23:59:59+00:00
Accession:  0001558370-23-005100
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Agile Therapeutics receives Nasdaq deficiency notice for negative stockholders' equity
--------------------------------------------------------------------------------

- Stockholders' equity of -$5.545M as of Dec 31, 2022, below Nasdaq's $2.5M minimum requirement.
- Company has until May 11, 2023 to submit a compliance plan to regain listing compliance.
- No immediate effect on Nasdaq listing; company intends to submit a plan and consider options.
- Alternative compliance standards (market value or net income) also not met.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1261249/000155837023005100/0001558370-23-005100-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1261249/000155837023005100/agrx-20230327x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-005100

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer